# OnCo record paltusotine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/paltusotine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "paltusotine" ;
  schema:name "Paltusotine"@en ;
  schema:alternateName "CRN00808"@en, "Palsonify" ;
  schema:description "Paltusotine is the first somatostatin-type drug that works as a once-daily pill instead of a monthly injection. It was approved in 2025 for acromegaly and is being tested for the flushing and diarrhoea of carcinoid syndrome from small-bowel neuroendocrine tumours."@en ;
  schema:url <https://onco.cc/drugs/paltusotine/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:status "approved" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Oral non-peptide somatostatin receptor 2 agonist" ;
  onco:approval "US 2025: Acromegaly in adults" ;
  onco:related <https://onco.cc/drugs/octreotide-lanreotide/> ;
  onco:cancers <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:companies <https://onco.cc/companies/crinetics-pharmaceuticals/> .